Drugs to Enhance or Inhibit Sinus Node Activity

Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988;395:233-253. Hermsmeyer K, Mishra S, Miyagawa K, Minshall R. Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for T-type calcium antagonists. Clin Ther 1997;19(Suppl A):18-26. DiFrancesco D, Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991; 351:145-147. Zaza A, Rocchetti M, DiFrancesco D. Modulation of the hyperpolarization activated current (If) by adenosine in rabbit sinoatrial myocytes. Circulation 1996;94:734-741. Zaza A, Robinson RB, DiFrancesco D. Basal responses of the L-type Ca2+ and hyperpolarization-activated currents to autonomic agonists in the rabbit sinoatrial node. J Physiol 1996;491:347-355. Reiffen M, Eberlein W, Muller P, Psiorz M, Noll R, Heider J, Lillie C, Kobinger W, Luger P. Specific bradicardic agents. Chemistry, pharmacology and structure-activity relationships of substituted benzazepinones, a new class of of compounds exerting antiischemic properties. J Med Chem 1990; 33:1496-1504. Frishman WH, Gabor R, Pepine C, Cavosoglu E. Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor. Am Heart J 1996;131:204-210. Nakajima T, Kurachi Y, Ito H, Takikawa R, Sugimoto T. Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms. Circ Res 1989;64:297-303. Pappano AJ, Mubagwa K. Actions of muscarinic agents and adenosine on the heart. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System, 2nd ed. New York: Raven Press, 1991;1765-1776. Hartzell CH. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog Biophys Molec Biol 1988;52:165-247. Frishman WH, Pepine CJ, Weiss RJ, Baiker WM. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group. JACC 1995;26:305-312. Glasser SP, Michie DD, Thadani U, Baiker WM. Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators. Am J Cardiol 1997;79:1401-1405. Viskin S, Belhassen B, Roth A, Reichter M, Averbuch M, Sheps D, Shalabye E, Laniado S. Aminophyilline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Int Med 1993;118:279-281. Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB. Electrophysiologic effects of adenosine in the transplanted human heart: Evidence of supersensitivity. Circulation 1990;81:821-828. Flammang D, Luiizy J, Wayneberger M. Re-initiation of the vasovagal syndrome by adenosine 59 triphosphate test: Assesment of the best therapy. PACE 1990;13:539. Brignole M, Menozzi C, Alboni P, Oddone D, Gianfranchi L, Gaggioli G, Lolli G, Paparella N. The effect of exogenous adenosine in patients with neurally-mediated syncope and sick sinus syndrome. PACE 1994;17:2211-2216. Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Int Med 1991; 151:2425-2429. Sra JS, Jazayeri MR, Avitall B, Dhala A, Deshpande S, Blanck Z, Akhtar M. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. New Engl J Med 1993;328:1085-1090. Alboni P, Ratto B, Cappato R, Rossi P, Gatto E, Antonioli GE. Clinical effects of oral theophylline in sick sinus syndrome. Am Heart J 1991;122:1361-1367. Abboud FM. Neurocardiogenic syncope. New Engl J Med 1993;328:117-120. Krahn AD, Yee R, Klein GJ, Morillo C. Inappropriate sinus tachycardia: Evaluation and therapy. J Cardiovasc Electrophys 1995;6:1124-1128. Madrid AH, Mestre JL, Moro C, Vivas E, Tejero I, Novo L, Marin E, Orellana L. Heart rate variability and inappropriate sinus tachycardia after catheter ablation of supraventricular tachycardia. Eur Heart J 1995;16:1637-1640. Friedman PL, Stevenson WG, Kocovic DZ. Autonomic dysfunction after catheter ablation. J Cardiovasc Electrophys 1996;7:450-459. Kocovic DZ, Harada T, Shea JB, Soroff D, Friedman PL. Alterations of heart rate and of heart rate variability after radiofrequency catheter ablation of supraventricular tachycardia. Delineation of parasympathetic pathways in the human heart. Circulation 1993;88:1671-1681. Morillo CA, Klein GJ, Thakur RK, Li H, Zardini M, Yee R. Mechanism of “inappropriate” sinus tachycardia. Role of sympathovagal balance. Circulation 1994;90:873-877. Bertolet BD, Eagle DA, Conti JB, Mills RM, Belardinelli L. Bradycardia after heart transplantation: Reversal with theophylline. JACC 1996;28:396-399.